People with Type 1 diabetes lack the hormone insulin. Insulin is vital to the body’s cells for the supply of energy and the progression of metabolic processes. Insulin must therefore be administered daily through multiple injections or an insulin pump. Self-regulating pumps, so-called artificial pancreas, are not available yet. In this unique collaboration between engineers in automatic control and computer-science and clinics treating patients with type 1 diabetes, the aim is to construct a link between the glucose meter and insulin pump so that it is regulated automatically. The goal of this research is to develop an automatic insulin pump. Can we prove end-user benefits for patients with type 1 diabetes by reducing the number of dangerous high or low glucose levels by providing better knowledge on how daily behaviour (physical activity, stress, sleep, pulse rate, food) can affect the individual insulin-dosage schedule?